The recent developments in immuno-oncology have opened an unprecedented avenue for
the emergence of vaccine strategies. Therapeutic DNA cancer vaccines are now considered …

Conventional cancer therapies such as chemotherapy, radiation therapy, and
immunotherapy due to the complexity of cancer have been unsuccessful in the complete …

Background Each year approximately 6,000 new cases of head and neck cancer are
registered in Poland. Human papillomavirus (HPV) and Epstein-Barr virus (EBV) have been …

In order to determine the role of human herpesvirus 6 (HHV-6) in human disease, several
confounding factors, including methods of detection, types of controls, and the ubiquitous …

Simple Summary Many different viruses are known to cause cancer. It is well known that
human papillomavirus is a causative agent of cervical carcinoma. What is more controversial …

Human herpesviruses (HHV) cause a variety of clinically relevant conditions upon primary
infection of typically young and immunocompetent hosts. Both primary infection and …

Infectious susceptibility is a component of many inborn errors of immunity. Nevertheless,
antibiotic use is often used as a surrogate in history taking for infectious susceptibility …

Kaposi's sarcoma-associated herpesvirus (KSHV) is the etiologic agent of Kaposi's sarcoma
(KS). It is endemic in a number of sub-Saharan African countries with infection rate of> 50 …

Viral interferon regulatory factor 1 (vIRF1), a Kaposi sarcoma herpesvirus protein,
destabilizes p53 by inhibiting p53 acetylation and Hdm2 phosphorylation. This leads to …

Several human herpes viruses (HHVs) exert oncogenic potential leading to malignant
transformation of infected cells and/or tissues. The molecular processes induced by viral …